Now accepting Telehealth appointments. Schedule a virtual visit.

PGT-A, costly and unreliable yet marketed vigorously [PR]

Dr. Gleicher joins two prominent colleagues in warning against the widespread utilization of PGT-A, in an opinion paper just published in Trends in Molecular Medicine. Learn more in our press release here.

Norbert Gleicher, MD

Norbert Gleicher, MD, FACOG, FACS

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.

Follow on LinkedIn    

Watch his videos on YouTube    

 


We have helped women bring over
17,800 babies into the world.

DISCOVER YOUR TREATMENT OPTIONS

 

You Might Also Enjoy...

March VOICE

We welcome all of our readers to the March issue of The CHR VOICE, which, as usual, in the new and expanded format offers a broad potpourri of articles for patients and laypeople as well as professional physicians and scientists working in reproductive med

The Voice February 2023

We are very pleased to offer the February 2023 issue of THE CHR VOICE and want to take the opportunity of this introduction to direct the attention of our readers...

The Voice January 2023

With this January issue, we are very pleased for the year 2023 to welcome back to TheVOICE; the monthly newsletter of the CHR,-you, our reader.

The Voice December 2022

With the year 2002 is almost behind us, it is easy to conclude that it on many different levels was an unusually tumultuous year.

The Voice November 2022

The CHR is delighted to offer the VOICE's November issue to our readers, as always attempting to present material for our very diverse readership.